“FORMULATION AND CHARACTERIZATION OF NANOSTRUCTURED LIPID CARRIERS OF TOLBUTAMIDE FOR THE TREATMENT OF TYPE II DIABETES”, CMN, vol. 6, no. 2, pp. 7092–7101, Nov. 2024, Accessed: Jun. 13, 2025. [Online]. Available: http://cahiersmagellanes.com/index.php/CMN/article/view/1040